(2024). The Benefit of Neutrophil to Lymphocyte Ratio vs Platelet to Lymphocyte Ratio as New Indicators of Erythropoietin Resistance in Patients Receiving Hemodialysis. test, 97(1), 4268-4274. doi: 10.21608/ejhm.2024.395544
. "The Benefit of Neutrophil to Lymphocyte Ratio vs Platelet to Lymphocyte Ratio as New Indicators of Erythropoietin Resistance in Patients Receiving Hemodialysis". test, 97, 1, 2024, 4268-4274. doi: 10.21608/ejhm.2024.395544
(2024). 'The Benefit of Neutrophil to Lymphocyte Ratio vs Platelet to Lymphocyte Ratio as New Indicators of Erythropoietin Resistance in Patients Receiving Hemodialysis', test, 97(1), pp. 4268-4274. doi: 10.21608/ejhm.2024.395544
The Benefit of Neutrophil to Lymphocyte Ratio vs Platelet to Lymphocyte Ratio as New Indicators of Erythropoietin Resistance in Patients Receiving Hemodialysis. test, 2024; 97(1): 4268-4274. doi: 10.21608/ejhm.2024.395544